Bradley Whitener

7PUBLICATIONS
132CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Innate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 08, 2024
Computationally restoring the potency of a clinical antibody against Omicron.

Thomas A Desautels, Kathryn T Arrildt, Adam T Zemla

|Sep 13, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.

Guillaume B E Stewart-Jones, Sayda M Elbashir, Kai Wu

|Jan 13, 2023
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.

Kimberly A Dowd, Devika Sirohi, Scott D Speer

|Apr 01, 2022
Defining the risk of SARS-CoV-2 variants on immune protection.

Marciela M DeGrace, Elodie Ghedin, Matthew B Frieman

|Jan 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.

Peter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto

|Jan 04, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters.

Michael Diamond, Peter Halfmann, Tadashi Maemura

Pageof 2